SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-16-001172
Filing Date
2016-09-13
Accepted
2016-09-13 17:10:23
Documents
5
Period of Report
2016-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K appy_8k.htm 8-K 27774
2 EXHIBIT 2.1 ex2x1.htm EX-2.1 243575
3 EXHIBIT 10.1 ex10x1.htm EX-10.1 123860
4 EXHIBIT 10.2 ex10x2.htm EX-10.2 69267
5 EXHIBIT 99.1 ex99x1.htm EX-99.1 11910
  Complete submission text file 0001079973-16-001172.txt   477801
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 161883434
SIC: 2835 In Vitro & In Vivo Diagnostic Substances